The Dixie Group, Inc.
DXYN
$0.5597
$0.02975.60%
| Weiss Ratings | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.85 | |||
| Price History | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 5.11% | |||
| 30-Day Total Return | -20.08% | |||
| 60-Day Total Return | -17.69% | |||
| 90-Day Total Return | -36.40% | |||
| Year to Date Total Return | -13.89% | |||
| 1-Year Total Return | 3.65% | |||
| 2-Year Total Return | -33.39% | |||
| 3-Year Total Return | -83.54% | |||
| 5-Year Total Return | -51.33% | |||
| 52-Week High % Change | -49.52% | |||
| 52-Week Low % Change | 26.89% | |||
| Price | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.05 | |||
| 52-Week Low Price | $0.42 | |||
| 52-Week Low Price (Date) | Feb 13, 2025 | |||
| 52-Week High Price (Date) | Oct 28, 2024 | |||
| Valuation | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.71M | |||
| Enterprise Value | 120.16M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.20 | |||
| Earnings Per Share Growth | -88.07% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.03 | |||
| Price/Book (Q) | 0.33 | |||
| Enterprise Value/Revenue (TTM) | 0.45 | |||
| Price | $0.56 | |||
| Enterprise Value/EBITDA (TTM) | 20.97 | |||
| Enterprise Value/EBIT | -74.35 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 14.46M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 706 876 5800 | |||
| Address | 475 Reed Road Dalton, GA 30720 | |||
| Website | www.thedixiegroup.com | |||
| Country | United States | |||
| Year Founded | 1920 | |||
| Profitability | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -0.60% | |||
| Profit Margin | -0.98% | |||
| Management Effectiveness | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.52% | |||
| Return on Equity | -- | |||
| Income Statement | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 267.31M | |||
| Total Revenue (TTM) | 267.31M | |||
| Revenue Per Share | $18.49 | |||
| Gross Profit (TTM) | 69.58M | |||
| EBITDA (TTM) | 5.73M | |||
| EBIT (TTM) | -1.62M | |||
| Net Income (TTM) | -2.64M | |||
| Net Income Avl. to Common (TTM) | -2.64M | |||
| Total Revenue Growth (Q YOY) | -5.39% | |||
| Earnings Growth (Q YOY) | -68.66% | |||
| EPS Diluted (TTM) | -0.20 | |||
| EPS Diluted Growth (Q YOY) | -67.96% | |||
| Balance Sheet | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.05M | |||
| Cash Per Share (Q) | $0.07 | |||
| Total Current Assets (Q) | 112.79M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 23.27M | |||
| Current Ratio (Q) | 2.540 | |||
| Book Value Per Share (Q) | $1.60 | |||
| Total Assets (Q) | 194.70M | |||
| Total Current Liabilities (Q) | 44.40M | |||
| Total Debt (Q) | 113.50M | |||
| Total Liabilities (Q) | 171.43M | |||
| Total Common Equity (Q) | 23.27M | |||
| Cash Flow | DXYN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 13.99M | |||
| Cash from Financing (TTM) | -11.02M | |||
| Net Change in Cash (TTM) | 880.00K | |||
| Levered Free Cash Flow (TTM) | 8.07M | |||
| Cash from Operations (TTM) | -2.09M | |||
